WANDA BEARING
920002
CG MED EQUIP.
838810
SUZHOUBEARING
430418
4
COCYBER
835207
5
Guangdong Create Century Intelligent Equipment Group Corporation
300083
US Stock MarketDetailed Quotes
CVKD Cadrenal Therapeutics
- 20.000
- 0.0000.00%
Close Feb 25 16:00 ET
- 19.300
- -0.700-3.50%
Pre 04:14 ET
35.65MMarket Cap-3.25P/E (TTM)
20.670High19.500Low79.77KVolume20.430Open20.000Pre Close1.61MTurnover6.62%Turnover RatioLossP/E (Static)1.78MShares20.78552wk High10.45P/B24.11MFloat Cap5.40052wk Low--Dividend TTM1.21MShs Float101.250Historical High--Div YieldTTM5.85%Amplitude5.400Historical Low20.161Avg Price1Lot Size
Cadrenal Therapeutics News
Cadrenal Therapeutics Is Maintained at Buy by HC Wainwright & Co.
H.C. Wainwright Maintains Cadrenal Therapeutics(CVKD.US) With Buy Rating, Cuts Target Price to $32
Noble Financial Maintains Cadrenal Therapeutics(CVKD.US) With Buy Rating, Cuts Target Price to $45
Analysts' Opinions Are Mixed on These Healthcare Stocks: Staar Surgical (STAA), Cadrenal Therapeutics, Inc. (CVKD) and Allogene Therapeutics (ALLO)
Cadrenal Therapeutics Analyst Ratings
Buy Rating Affirmed for Cadrenal Therapeutics on Strong Clinical and Financial Prospects
Cadrenal Therapeutics Analyst Ratings
Analysts Conflicted on These Healthcare Names: Cadrenal Therapeutics, Inc. (CVKD), Protara Therapeutics (TARA) and Spruce Biosciences (SPRB)
Cadrenal Therapeutics, Inc. (CVKD) Receives a Buy From Noble Financial
Noble Capital Markets Initiates Coverage On Cadrenal Therapeutics With Outperform Rating, Announces Price Target of $4
Cadrenal Therapeutics Analyst Ratings
HC Wainwright & Co. Initiates Coverage On Cadrenal Therapeutics With Buy Rating, Announces Price Target of $3
Cadrenal Therapeutics Analyst Ratings
No More
Trending Stocks
Discussing
FOMC leaves rates unchanged, how will you adjust your portfolio?
FOMC left the target Federal Funds rate unchanged at at target of 4.25%-4.5%, how will you adjust your portfolio?
Moo Live
Jan 30 03:25
FOMC Press Conference, January 29, 2025